DFDA

Nifedipine (extended-release)

Treatment for Maternal Hypertensive Disorders

Typical Dosage: 30-90 mg once daily

Effectiveness
87%
Safety Score
71%
Clinical Trials
150
Participants
4K

Comparative Safety Scale(Higher is safer)

Cyanide☠ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
71
DangerousModerateSafe
Treatment Details
Dosage Range
30-90 mg once daily
Time to Effect
30-60 minutes (oral)
Treatment Duration
Until delivery
Evidence Quality
HIGH
Number Needed to Treat (NNT)
6(Treat 6 patients to see 1 additional successful outcome)
Confidence Score
91%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$150
Monitoring:$1,000
Side Effect Mgmt:$200
Total Annual:$1,350
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.3
Outcome-Based Costs
Cost per Responder
$1,588
Prescription Access Economics
Physician Visit Cost
$1,000/year
Time Cost
$240/year
Travel + wait time
Insurance Admin Cost
$240/year
Prior auth, claims
Rx Price
$150/year
Risk Assessment
Misuse Risk
MODERATE
Missed Diagnosis Risk
LOW
Requires Monitoring
Yes
Needs lab work/checkups
Nifedipine (extended-release) Outcomes

for Maternal Hypertensive Disorders

Efficacy Outcomes
Overall Effectiveness
+87%
Response Rate
+85%
Common Side Effects
Headache
+20%
Flushing
+15%
Dizziness
+10%
Peripheral edema
+7%

Sources:

ahajournals.org
mdedge.com
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov